Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia

Summary

The purpose of this study is to evaluate safety, feasibility and maximum tolerated dose of NK cells cultured in vitro as adjuvant treatment of patients with chronic myeloid leukemia candidates to allogenic bone marrow transplantation or refractory to conventional treatment.

Timeline

Start

2019-03

Primary completion

2021-03

Completion

2023-03

Drugs

Indications